| 000 | 01835 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515141235.0 | ||
| 264 | 0 | _c20090724 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1432-1912 | ||
| 024 | 7 |
_a10.1007/s00210-008-0351-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJakubowski, A | |
| 245 | 0 | 0 |
_aS-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia. _h[electronic resource] |
| 260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cMar 2009 |
||
| 300 |
_a281-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xbiosynthesis |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEndotoxemia _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xbiosynthesis |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aLipopolysaccharides |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xbiosynthesis |
| 650 | 0 | 4 |
_aNitroso Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aPeroxidase _xmetabolism |
| 650 | 0 | 4 |
_aPulmonary Edema _xetiology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSerum Albumin _xadministration & dosage |
| 650 | 0 | 4 | _aSerum Albumin, Human |
| 700 | 1 | _aMaksimovich, N | |
| 700 | 1 | _aOlszanecki, R | |
| 700 | 1 | _aGebska, A | |
| 700 | 1 | _aGasser, H | |
| 700 | 1 | _aPodesser, B K | |
| 700 | 1 | _aHallström, S | |
| 700 | 1 | _aChlopicki, S | |
| 773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 379 _gno. 3 _gp. 281-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00210-008-0351-2 _zAvailable from publisher's website |
| 999 |
_c18319682 _d18319682 |
||